课题基金 / 基金详情

Carrier-Mediated Delivery of Therapeutic Proteins into the Brain

Carrier-Mediated Delivery of Therapeutic Proteins into the Brain
载体介导的治疗性蛋白质向大脑的递送
批准号：
270546
负责人：
Beilhartz Greg L
金额：
$4.92万
依托单位：
Hospital for Sick Children (Toronto)
依托单位国家：
加拿大
项目类别：
Fellowship Programs
财政年份：
2012
资助国家：
加拿大
项目状态：
已结题
起止时间：
2012-10-01 至 2015-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=270546&lang=en
关键词：
Blood-Brain-Barrier Carrier Protein Crm197 Diphtheria Toxin Endocytosis Fragile X Syndrome Intracellular Delivery Molecule Protein Replacement Therapy Receptor-Mediated Transcytosis Toxin-Mediated Delivery

项目摘要

项目成果

Beilhartz Greg L的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Fragile X Syndrome (FXS) is the most common single-gene cause of autism and the most common form of inherited mental retardation in boys. The disease is characterized by a range of symptoms from characteristic hand movements to severe mental disability. F
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Local dissociation of DNA/DNA and DNA/RNA from the ribonuclease H active site of HIV-1 reverse transcriptase: Implications for (+)-strand DNA synthesis and drug design
  • 批准号：
    184425
  • 项目类别：
    Studentship Programs
  • 资助金额：
    $7.65万
  • 财政年份：
    2008
  • 负责人：
    Beilhartz Greg L
  • 依托单位：
    McGill University
海外基金